ArticleAmerican journal of ophthalmology2026
Application of a Quantitative Vascular Severity Score in Retinopathy of Prematurity in the United States and India: New Insights Into Disease Epidemiology and Pathophysiology.
Article in American journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeTo compare the epidemiology and phenotypic characteristics of 2 populations of patients with retinopathy of prematurity (ROP) using a quantitative artificial intelligence (AI)-derived vascular severity score (VSS).
methodsWe retrospectively analyzed 2 data sets of ROP images: (1) The iROP data set including 1019 babies and 6552 eye-level examinations developed as part of a large US multicenter cohort study from 2012 to 2020. (2) 8281 consecutive ROP telemedicine examinations from 2363 babies in the Indian Aravind Eye Care System (AECS), from 2019 to 2020. We analyzed all eye examinations using the iROP DL system, which outputs a VSS from 1 to 9. The main outcome was the relationship between the VSS and the zone, stage, and extent of stage 3 in each data set, assessed using generalized estimating equations to account for the correlation from bilateral and repeated examinations.
resultsIn both data sets, higher VSS was associated with higher stage (P < .001 for all stages in both data sets), higher extent of stage 3 (i-ROP, P =.004, and AECS, P < .001), and a more posterior zone for a given stage of ROP (i-ROP: stage 1, P = .04, stage 2, P < .001, and stage 3, P < .001; AECS: stage 1, P < .001, and stage 3, P < .001). For any given stage, the VSS was lower in the AECS data set than in the i-ROP data set (all P < .001).
conclusionsIn both populations, the VSS was associated with more posterior zone and higher ROP stage/extent, though on average the VSS was lower in the AECS population. A correlation between measured VSS and intraocular vascular endothelial growth factor concentration might explain both findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.